Tracer library / [188Re]Re-SSS/Lipiodol
[188Re]Re-SSS/Lipiodol
Also written as Re-188-SSS-Lipiodol; [188Re]Re-SSS/Lipiodol
- Radionuclide
- Re-188
- Modality
- —
- Production route
- —
- Stage
- —
- Syntheses indexed
- 0
Published syntheses
No synthesis has been parsed for this agent yet.
Clinical literature
Clinical studies in the indexed corpus, ordered by design (multicentre, prospective, retrospective, others, case reports last) and then by year. Titles and links only, as published; this is not a summary of the evidence.
- Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with 188Re-SSS Lipiodol radioembolization.2019 · Eur J Nucl Med Mol Imaging · Clinical study
Need this precursor?We can point you to suppliers for [188Re]Re-SSS/Lipiodol, or handle the enquiry for you.
Get in touchNotes
Added at stage 39 (2026-09-27) from a reverse search of the PubMed corpus's own unattached articles (articles that named a real compound not yet in this reference): 4 article(s) found under this name, not yet individually researched. Target/mechanism, clinical application, indications, approval, modality, stage and production route are intentionally left empty. PMIDs: 14691613, 15094449, 21106381, 30715571.